Trial intelligence / Profile preview

Phase II Study of ASP0456 (Linaclotide) in Chronic Constipation

NCT02425722Phase 2Completed

Sponsor
Astellas Pharma
Start
Apr 2015
Primary completion
Oct 2015
Modality
Peptides
Countries
1
01

Overview

A Phase 2 trial of linaclotide in chronic constipation, sponsored by Astellas Pharma. Started Apr 2015; status: completed.

02

Drugs

linaclotide
03

Conditions

chronic constipation

Beyond the preview

Go deeper on NCT02425722.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT02425722.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call